正文共2700字 3图预计阅读时间8分钟2025年5月27日,GLP-1新锐派格生物正式登陆港交所,中金公司担任独家保荐人。发行价每股15.60港元,发行市值达60.21亿港元,成功募集3亿港元。根据招股书披露的信息:派格生物计划将募集资金中的50.2%用于推进长效GLP-1受体激动剂PB-119的商业化进程及其适应症范围的拓展;34.5%的资金将投入到GLP-1/GCG双重受体激动剂PB-718...
Source Link正文共2700字 3图预计阅读时间8分钟2025年5月27日,GLP-1新锐派格生物正式登陆港交所,中金公司担任独家保荐人。发行价每股15.60港元,发行市值达60.21亿港元,成功募集3亿港元。根据招股书披露的信息:派格生物计划将募集资金中的50.2%用于推进长效GLP-1受体激动剂PB-119的商业化进程及其适应症范围的拓展;34.5%的资金将投入到GLP-1/GCG双重受体激动剂PB-718...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.